Cogent Biosciences Inc. has described compounds acting as fibroblast growth factor receptor (FGFR) inhibitors reported to be useful for the treatment of achondroplasia, cancer, craniosynostosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback